Glutathione/Inosine
- Generic Name
- Glutathione/Inosine
Clinical Study in the Treatment of Patients With COVID-19
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2021-10-11
- Lead Sponsor
- Pharma VAM
- Target Recruit Count
- 330
- Registration Number
- NCT04780672
- Locations
- 🇷🇺
Yaroslavl Regional Clinical Hospital for War Veterans - The International Center for the Elderly "Healthy Longevity", Yaroslavl, Russian Federation
A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy
- First Posted Date
- 2010-01-28
- Last Posted Date
- 2022-07-25
- Lead Sponsor
- Cellectar Biosciences, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT01058512
- Locations
- 🇺🇸
Orlando Immunology Center, Orlando, Florida, United States
🇺🇸UMASS Memorial Medical Center, Worcester, Massachusetts, United States
🇺🇸MetroWest Medical Center, Framingham, Massachusetts, United States
Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy
Phase 1
Completed
- Conditions
- Hepatitis C
- First Posted Date
- 2006-09-07
- Last Posted Date
- 2007-12-21
- Lead Sponsor
- Cellectar Biosciences, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00372983
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath